Levels of adenosine deaminase and dipeptidyl peptidase IV in patients with panic disorder

被引:0
|
作者
Yarpuz, Asli Yolac [1 ]
Yilmaz, Ayseguel [1 ]
Soykan, Atilla [1 ]
Elguen, Serenay [2 ]
Kumbasar, Hakan [1 ]
机构
[1] Ankara U Tip Fak, Psikiyatri AD, Ankara, Turkey
[2] Ankara U Biyokimya AD, Ankara, Turkey
关键词
panic disorder; adenosine deaminase; dipeptidyl peptidase IV; immune system;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Adenosine deaminase and dipeptidyl peptidase IV are enzymes connected to T cells that play an important role in immune system functioning. In this study, in order to understand the immune processes in panic disorder, we determined the serum levels of adenosine deaminase and dipeptidyl peptidase IV in medication-free panic disorder patients and compared them to those of healthy controls. Method. Enzymes levels were determined in blood samples of 24 healthy controls and 33 panic disorder patients diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders-IV that were medication free during the previous month and medically healthy. Results: Levels of both enzymes were significantly higher in panic disorder patients than in the controls (P < 0.001 for adenosine deaminase and P < 0.05 for dipeptidyl peptidase IV). The levels of the enzymes did not correlate with sociodemographic variables, duration of the disorder presence of agoraphobia, presence of stressors, number of panic attack symptoms, and Hamilton depression and anxiety rating scale scores. In addition, the 2 enzymes' levels did not correlate with each other. There was a correlation between Hamilton anxiety rating scale score and the number of panic attack symptoms (P < 0.001); however Hamilton anxiety rating scale scores were not correlated with the other variables. Conclusion; Our results suggest that there may be a primary or secondary impaired immune state in the course of panic disorder as there is in many other psychiatric disorders, such as major depression. Future studies with larger samples are needed to clarify the relationship between the immune system and panic disorder.
引用
收藏
页码:149 / 156
页数:8
相关论文
共 50 条
  • [21] Dipeptidyl-peptidase IV in patients with short bowel syndrome
    Farriol, M
    Pita, AM
    Fernandez-Bustos, MA
    Delgado, G
    CLINICAL NUTRITION, 2005, 24 (06) : 1099 - 1104
  • [22] DIPEPTIDYL PEPTIDASE-IV IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    STANCIKOVA, M
    LOJDA, Z
    LUKAC, J
    RUZICKOVA, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1992, 10 (04) : 381 - 385
  • [23] Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV
    Tanaka, S
    Murakami, T
    Horikawa, H
    Sugiura, M
    Kawashima, K
    Sugita, T
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1997, 19 (01): : 15 - 24
  • [24] Tackling dipeptidyl peptidase IV in neurological disorders
    Al-Badri, Ghaith
    Leggio, Gian Marco
    Musumeci, Giuseppe
    Marzagalli, Rubina
    Drago, Filippo
    Castorina, Alessandro
    NEURAL REGENERATION RESEARCH, 2018, 13 (01) : 26 - 34
  • [25] Some properties of bacterial dipeptidyl peptidase IV
    Ryo, M
    CELL-SURFACE AMINOPEPTIDASES: BASIC AND CLINICAL ASPECTS, 2001, 1218 : 395 - 399
  • [26] Recent patents of dipeptidyl peptidase IV inhibitors
    Mendieta, Laura
    Tarrago, Teresa
    Giralt, Ernest
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (11) : 1693 - 1741
  • [27] Immunoglobulin levels in panic disorder patients
    Nahar, Zabun
    Khanum, Sayema
    Harun, Saima
    Islam, Sheikh Nazrul
    Sobhan, Md. Abdus
    Islam, Md Saiful
    Hasnat, Abul
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 25 (01) : 149 - 153
  • [28] Dipeptidyl-peptidase IV-β -: Further characterization and comparison to dipeptidyl-peptidase IV activity of CD26
    Blanco, J
    Nguyen, C
    Callebaut, C
    Jacotot, E
    Krust, B
    Mazaleyrat, JP
    Wakselman, M
    Hovanessian, AG
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 256 (02): : 369 - 378
  • [29] Effects of combination treatment with dipeptidyl peptidase IV inhibitor and sulfonylurea on glucose levels in rats
    Takasaki, K
    Nakajima, T
    Ueno, K
    Nomoto, Y
    Higo, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 95 (02) : 291 - 293
  • [30] Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease
    Hildebrandt, M
    Rose, N
    Rüter, J
    Salama, A
    Mönnikes, H
    Klapp, BF
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (10) : 1067 - 1072